PDCD1 and neoplasm: In summary, we highlighted how regulating imbalance between CD8+ T cells and tumor burden with CA4-NPs + DC101 via tumor vascular disruption and normalization represented an innovative strategy to enhance the effectiveness of anti-PD-1 therapy.